Login to MyKarger

New to MyKarger? Click here to sign up.



Login with Facebook

Forgot your password?

Authors, Editors, Reviewers

For Manuscript Submission, Check or Review Login please go to Submission Websites List.

Submission Websites List

Institutional Login
(Shibboleth or Open Athens)

For the academic login, please select your country in the dropdown list. You will be redirected to verify your credentials.

Diagnostics and Staging

HCC Diagnosis with Liver-Specific MRI – Close to Histopathology

Bartolozzi C. · Battaglia V. · Bozzi E.

Author affiliations

Division of Diagnostic and Interventional Radiology, University of Pisa, Pisa, Italy

Related Articles for ""

Dig Dis 2009;27:125–130

Do you have an account?

Login Information





Contact Information











I have read the Karger Terms and Conditions and agree.



Login Information





Contact Information











I have read the Karger Terms and Conditions and agree.



To view the fulltext, please log in

To view the pdf, please log in

Buy

  • FullText & PDF
  • Unlimited re-access via MyKarger
  • Unrestricted printing, no saving restrictions for personal use
read more

CHF 38.00 *
EUR 35.00 *
USD 39.00 *

Select

KAB

Buy a Karger Article Bundle (KAB) and profit from a discount!

If you would like to redeem your KAB credit, please log in.


Save over 20% compared to the individual article price.
Learn more

Rent/Cloud

  • Rent for 48h to view
  • Buy Cloud Access for unlimited viewing via different devices
  • Synchronizing in the ReadCube Cloud
  • Printing and saving restrictions apply

Rental: USD 8.50
Cloud: USD 20.00


Select

Subscribe

  • Access to all articles of the subscribed year(s) guaranteed for 5 years
  • Unlimited re-access via Subscriber Login or MyKarger
  • Unrestricted printing, no saving restrictions for personal use
read more

Subcription rates


Select

* The final prices may differ from the prices shown due to specifics of VAT rules.

Article / Publication Details

First-Page Preview
Abstract of Diagnostics and Staging

Published online: June 22, 2009
Issue release date: June 2009

Number of Print Pages: 6
Number of Figures: 3
Number of Tables: 0

ISSN: 0257-2753 (Print)
eISSN: 1421-9875 (Online)

For additional information: https://www.karger.com/DDI

Abstract

Thanks to the sensible and continuous improvements achieved, magnetic resonance imaging (MRI) can nowadays be considered the most accurate modality to image the liver. Moreover, the technique is the only one able to provide at the same time information about intracellular and vascular changes occurring in parenchymas. For these reasons, MRI plays a major role in the surveillance and follow-up of patients with cirrhosis. If a baseline MR study investigates the progressive alteration of lesion architecture, grading, stromal component, as well as intracellular content of fat, glycogen, or metal ions, thus leading to a frequent confident diagnosis of lesion nature, a dynamic study provides additional information about lesion vascular enhancement, which may represent the only clue for the differential diagnosis between premalignant and malignant lesions. In addition, the introduction of hepatobiliary contrast agents has further implemented the diagnostic confidence of the technique, permitting to explore the so-called grey area in which significant histological changes are already present without an evident arterial supply of the nodule. Although in the evaluation of liver pathologies MRI is mainly applied in the study of cirrhosis, the technique also plays a fundamental role in the assessment of other primitive liver malignancies, such as fibrolamellar carcinoma or cholangiocarcinoma. In these cases in particular, MRI is required to pose a differential diagnosis with other liver malignancies (such as metastases), and, once the nature of the neoplasm is assessed, to give an accurate locoregional staging.

© 2009 S. Karger AG, Basel


References

  1. Willatt JM, Hussain HK, Adusumilli S, et al: MRI of hepatocellular carcinoma in the cirrhotic liver: challenges and controversies. Radiology 2008;247:311–330.
  2. Hussain HK, Londy FJ, Francis IR, et al: Hepatic arterial phase MRI with automated bolus detection three-dimensional fast gradient-recalled echo sequence: comparison with test bolus method. Radiology 2003;226:558–566.
  3. Ito K: Hepatocellular carcinoma: conventional MRI findings including gadolinium-enhanced dynamic imaging. Eur J Radiol 2006;58:186–199.
  4. Lavelle MT, Lee VS, Rofsky NM, et al: Dynamic contrast enhanced three-dimensional MRI of the liver parenchyma: source images and angiographic reconstructions to define hepatic arterial anatomy. Radiology 2001;218:389–394.
  5. Bartolozzi C, Cioni D, Donati F, et al: Focal liver lesions: MRI-pathologic correlation. Eur Radiol 2001;11:1374–1388.
  6. Ichikawa T, Haradome H, Hachiya J, et al: Diffusion-weighted MRI with a single-shot echoplanar sequence: detection and characterization of focal hepatic lesions. Am J Roentgenol 1998;170:397–402.
  7. Bartolozzi C, Crocetti L, Lencioni R, et al: Biliary and reticuloendothelial impairment in hepatocarcinogenesis: the diagnostic role of tissue specific MR contrast media. Eur Radiol 2007;17:2519–2530.
  8. Coleman WB: Mechanisms of human hepatocarcinogenesis. Curr Mol Med 2003;3:573–588.
  9. Theise ND, Park YN, Kojiro M: Dysplastic nodules and hepatocarcinogenesis. Clin Liver Dis 2002;6:497–512.
  10. Shinmura R, Matsui O, Kobayashi S, et al: Cirrhotic nodules: association between MRI signal intensity and intranodular blood supply. Radiology 2006;237:512–519.
    External Resources
  11. Goshima S, Kanematsu M, Kondo H: Diffusion-weighted imaging of the liver: optimizing b value for the detection and characterization of benign and malignant hepatic lesions. J Magn Reson Imaging 2008;28:691–697.
  12. Ichikawa T, Federle MP, Grazioli L, et al: Fibrolamellar hepatocellular carcinoma: pre- and post-therapy evaluation with CT and MRI. Radiology 2000;217:145–151.

Article / Publication Details

First-Page Preview
Abstract of Diagnostics and Staging

Published online: June 22, 2009
Issue release date: June 2009

Number of Print Pages: 6
Number of Figures: 3
Number of Tables: 0

ISSN: 0257-2753 (Print)
eISSN: 1421-9875 (Online)

For additional information: https://www.karger.com/DDI


Copyright / Drug Dosage / Disclaimer

Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.